Celgene

Celgene Corporation is a pharmaceutical company based in Summit, New Jersey, U.S. Its main product is Thalomid, used to treat bone marrow cancer as well as a form of leprosy. (Thalomid is a form of the infamous thalidomide sedative which was used in the 1950s until it was realized that it caused birth defects.) Another of Celgene's drugs is Revlimid which is used to treat the malignant blood disease MDS.

In 2006, sales were nearly US$900 million with profits of US$69 million.

Lobbying
Celgene spent $160,000 for lobbying in 2006. All of the money went to the lobbying firms - The Washington Group and Sidley Austin.

Personnel
Key executives and 2006 pay:
 * Sol J. Barer, Chairman and Chief Executive Officer, $16,084,329 (also exercised $33,719,410 in options)
 * Robert J. Hugin, Chief Operating Officer, $7,777,660
 * David W. Gryska, Chief Financial Officer, $263,730
 * Aart Brouwer, Divisional President, $835,247

Selected members of the Board of Directors:
 * Rodman L. Drake, Also Director of Jackson Hewitt and Student Loan Corporation (Sallie Mae)
 * Arthur Hull Hayes, Jr., Former Commissioner of the U.S. Food and Drug Administration under Ronald Reagan
 * Gilla Kaplan, Professor

Contact details
86 Morris Avenue Summit, NJ 07901 Phone: 908-673-9000 Fax: 908-673-9001 Web: http://www.celgene.com

Related SourceWatch articles

 * Pharmaceutical industry
 * War on Cancer